Expert Opinion on Drug Safety, Volume 21, Issue 11 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 21, Issue 11 (2022)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Volume 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention
Djordje S. Popovic, Theocharis Koufakis, Bojan Kovacevic, Manfredi Rizzo & Nikolaos Papanas
Pages: 1337-1339
Published online: 11 Oct 2022
First Page PreviewforImmune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention | Full Text | References | PDF (164.5 KB) | EPUB
  • 866 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects
Paola Di Nardo, Camilla Lisanti, Mattia Garutti, Silvia Buriolla, Martina Alberti, Roberta Mazzeo & Fabio Puglisi
Pages: 1341-1355
Published online: 05 Dec 2022
AbstractforChemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects | Full Text | References | PDF (760.5 KB) | EPUB
  • 5679 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review
Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety
Annesha White, Kimberly G. Fulda, Rachel Blythe, Michelle A. Chui, Emily Reeve, Richard Young, Anna Espinoza, Noah Hendrix & Yan Xiao
Pages: 1357-1364
Published online: 21 Nov 2022
AbstractforDefining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety | Full Text | References | PDF (279.3 KB) | EPUB
  • 236 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Fluoroquinolones: old drugs, putative new toxicities
Cecilia Bove, Robert A. Baldock, Oscar Champigneulle, Linda Martin & Charles L Bennett
Pages: 1365-1378
Published online: 21 Nov 2022
AbstractforFluoroquinolones: old drugs, putative new toxicities | Full Text | References | PDF (1.3 MB) | EPUB
  • 317 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
An umbrella review of systematic reviews on contributory factors to medication errors in health-care settings
Lina Naseralallah, Derek Stewart, Ruba Azfar Ali & Vibhu Paudyal
Pages: 1379-1399
Published online: 21 Nov 2022
AbstractforAn umbrella review of systematic reviews on contributory factors to medication errors in health-care settings | Full Text | References | PDF (565 KB) | EPUB | Supplemental
  • 4447 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

Meta-Opinion

Article
Pre-therapeutic evaluation and practical management of cardiovascular and renal toxicities in patients with metastatic radioiodine-refractory thyroid cancer treated with lenvatinib
Johanna Wassermann, Corinne Isnard Bagnis, Laurence Leenhardt, Stéphane Ederhy & Camille Buffet
Pages: 1401-1410
Published online: 07 Dec 2022
AbstractforPre-therapeutic evaluation and practical management of cardiovascular and renal toxicities in patients with metastatic radioiodine-refractory thyroid cancer treated with lenvatinib | Full Text | References | PDF (344.5 KB) | EPUB
  • 197 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Research

Article
Safety and effectiveness of empagliflozin according to body mass index in Japanese patients with type 2 diabetes: a subgroup analysis of a 3-year post-marketing surveillance study
Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Seiko Mizuno & Daisuke Nitta
Pages: 1411-1422
Published online: 10 Apr 2022
AbstractforSafety and effectiveness of empagliflozin according to body mass index in Japanese patients with type 2 diabetes: a subgroup analysis of a 3-year post-marketing surveillance study | Full Text | References | PDF (3.7 MB) | EPUB | Supplemental
  • 4979 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension
Sung-A Chang, Sang Hyun Lee, Jung Hyun Choi, Wook-Jin Chung, Jae Young Choi, Hyung-Kwan Kim, Hae-Ok Jung, Seong-Mi Park, Won-Jang Kim, Su Young Jung & Hyuk-Jae Chang
Pages: 1423-1432
Published online: 28 Apr 2022
AbstractforReal-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension | Full Text | References | PDF (994.1 KB) | EPUB
  • 483 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The use of hydroxyurea in the real life of MIOT network: an observational study
Paolo Ricchi, Antonella Meloni, Paolo Rigano, Laura Pistoia, Anna Spasiano, Massimo Allò, Giuseppe Messina, Antonella Quarta, Rosamaria Rosso, Alessandra Quota, Aldo Filosa, Aurelio Maggio & Alessia Pepe
Pages: 1433-1440
Published online: 17 Apr 2022
AbstractforThe use of hydroxyurea in the real life of MIOT network: an observational study | Full Text | References | PDF (342.7 KB) | EPUB
  • 173 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles